# US 6,730,693 B2 · Double salts of fumaric acid with a carnitine and an amino acid and food supplements, dietary supplements and drugs containing same

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 6,730,693 B2
- Document ID: US6730693B2
- Status: Granted
- Kind: B2
- Application number: 10/297,843
- Filed: 2002-12-11
- Published: 2003-09-11
- Granted: 2004-05-04
- Earliest claimed: 2000-06-14
- Assignees: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
- Inventors: Antonietta Buononato
- Web page: https://patentgrep.com/patent/US6730693B2

## CPC

- C07D 233/64: with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
- A23L 27/30: Artificial sweetening agents
- A23L 33/13: Nucleic acids or derivatives thereof (A23L33/145 takes precedence)
- A23L 33/15: Vitamins
- A23L 33/175: Amino acids
- A61K 31/205: Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
- A61K 31/7004: Monosaccharides having only carbon, hydrogen and oxygen atoms
- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A61P 3/02: Nutrients, e.g. vitamins, minerals
- A61P 39/00: General protective or antinoxious agents
- C07C 229/22: the carbon skeleton being further substituted by oxygen atoms
- C07C 229/26: having more than one amino group bound to the carbon skeleton, e.g. lysine
- C07C 279/14: being further substituted by carboxyl groups
- C07H 3/02: Monosaccharides
- A23V 2002/00: Food compositions, function of food ingredients or processes for food or foodstuffs
- C07B 2200/07: Optical isomers
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07H: SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS (derivatives of aldonic or saccharic acids C07C, C07D; aldonic acids, saccharic acids C07C59/105, C07C59/285; cyanohydrins C07C255/16; glycals C07D; compounds of unknown constitution C07G; polysaccharides, derivatives thereof C08B; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; sugar industry C13)
- A23V: INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- C07B: GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR (preparation of carboxylic acid esters by telomerisation C07C67/47; telomerisation C08F)

## Abstract

Double fumarates of L-carnitine or isovaleryl L-carnitine and an amino acid having formula (I) are disclosed which are useful as active ingredients of food supplements, dietary supplements or drugs. wherein: R is hydrogen or isovaleryl; and [A+] is a positively charged amino acid selected from the group consisting of creatine, ornithine, lysine, arginine and histidine.

## Claims

### Claim 1

A fumarate of formula (I):
wherein R is hydrogen or isovaleryl and [A+] is a positively charged amino acid selected from the group consisting of creatine, ornithine, lysine, arginine, and histidine.

### Claim 2 (depends on 1)

The fumarate of claim 1, selected from the group consisting of:
L-carnitine and creatine fumarate;
isovaleryl L-carnitine and creatine fumarate;
L-carnitine and ornithine fumarate;
isovaleryl L-carnitine and ornithine fumarate;
L-carnitine and lysine fumarate;
isovaleryl L-carnitine and lysine fumarate;
L-carnitine and arginine fumarate;
isovaleryl L-carnitine and arginine fumarate;
L-carnitine and histidine fumarate; and
isovaleryl L-carnitine and hystidine fumarate.

### Claim 3 (depends on 1)

A composition of a fumarate of general formula (I) as claimed in claim 1 as active principle and a pharmacologically acceptable excipient.

### Claim 4 (depends on 3)

The composition of claim 3, further comprising one or more other ingredients selected from antioxidants, coenzymes and minerals.

### Claim 5 (depends on 3)

The composition of claim 3, in the form of tablets, chewable tablets, pills, troches, lozenges, capsules, granulates or powders.

### Claim 6 (depends on 3)

The composition of claim 3, in unit dosage form, comprising as active ingredient a fumarate of formula (I) containing 50-2000, preferably 100-1000, mg of L-carnitine or isovaleryl L-carnitine as inner salt.

### Claim 7 (depends on 3)

The composition of claim 3, for human use as food supplement, dietary supplement or a drug.

### Claim 8 (depends on 3)

The composition of claim 3, for veterinary use as supplement for fodders.
